946605-55-6 Usage
Molecular weight
235.03 g/mol The molecular weight of the compound is 235.03 grams per mole, which is the mass of one mole of the compound.
Physical state
Clear, colorless liquid At room temperature, the compound is a clear and colorless liquid.
Boiling point
119-121°C The boiling point of the compound is between 119 and 121 degrees Celsius, which is the temperature range at which the compound changes from a liquid to a gas.
Density
1.593 g/mL The density of the compound is 1.593 grams per milliliter, which indicates the mass of the compound per unit volume.
Uses in organic synthesis
Intermediate in production of pharmaceuticals and agrochemicals 1-Bromo-2-(2,2-difluoro-ethoxy)-benzene is used as an intermediate in the synthesis of various organic compounds, particularly in the production of pharmaceuticals and agrochemicals.
Building block in advanced materials and specialty chemicals
The compound is also employed as a building block in the manufacture of advanced materials and specialty chemicals, which can be used in various applications.
Potential environmental hazard
Toxicity and bioaccumulation 1-Bromo-2-(2,2-difluoro-ethoxy)-benzene is considered to be a potential environmental hazard due to its toxic nature and the possibility of bioaccumulation in living organisms.
Check Digit Verification of cas no
The CAS Registry Mumber 946605-55-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,6,6,0 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 946605-55:
(8*9)+(7*4)+(6*6)+(5*6)+(4*0)+(3*5)+(2*5)+(1*5)=196
196 % 10 = 6
So 946605-55-6 is a valid CAS Registry Number.
946605-55-6Relevant articles and documents
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
-
Paragraph 0664-0666, (2021/04/23)
The present invention provides a compound of formula (Ia) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, solid forms, combinations of pharmacologically active agents, pharmaceutical compositions and methods of using such compounds and solid forms thereof to treat or prevent parasitic diseases, for example malaria.
